Investing.com -- Palvella Therapeutics Inc (NASDAQ:PVLA) stock gained 5.6% Monday following the publication of a systematic review in Clinical and Experimental Dermatology supporting the scientific ...
Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.
Publication includes a systematic review of 24 studies describing off-label cutaneous application of statins in porokeratosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results